HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LVMH Perfumes & Cosmetics Income Boosted By Dior In 2004

This article was originally published in The Rose Sheet

Executive Summary

A strong performance by Parfums Christian Dior in 2004, boosted by the Poison fragrance franchise and the brand's makeup line, contributed to 1.7% growth in the Perfumes & Cosmetics division's operating income, which reached $242.3 mil. (€1=$1.34) for the year, the company announced March 9

You may also be interested in...



Sephora Comp Store Sales Up Double-Digits In The U.S. In 2004

Sephora achieved double-digit comp store sales growth in 2004, marking the fourth consecutive year the beauty retailer's revenues in the region have advanced at that rate, LVMH reported Jan. 19

Christian Dior U.S. Turnaround Centered On Brand’s Fashion Heritage

The turnaround effort underway at Christian Dior Perfumes is aiming to drive sales of the LVMH division's fragrance and cosmetics business in the U.S. by reconnecting the brand to its fashion heritage, according to U.S. Cosmetics and Perfumes President Pamela Baxter

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel